Merck & Co Inc (NYSE: MRK) is 12.51% higher on its value in year-to-date trading and has touched a low of $99.14 and a high of $130.24 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The MRK stock was last observed hovering at around $122.77 in the last trading session, with the day’s loss setting it -0.11%.
Currently trading at $122.66, the stock is -2.89% and 0.21% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 10.74 million and changing -0.09% at the moment leaves the stock 10.86% off its SMA200. MRK registered 13.90% gain for a year compared to 6-month gain of 12.95%. The firm has a 50-day simple moving average (SMA 50) of $5.63 and a 200-day simple moving average (SMA200) of $49.03.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -2.22% loss in the last 1 month and extending the period to 3 months gives it a 18.23%, and is -0.14% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.72% over the week and 1.48% over the month.
Merck & Co Inc (MRK) has around 72000 employees, a market worth around $310.65B and $59.87B in sales. Current P/E ratio is 927.84 and Fwd P/E is 12.57. Profit margin for the company is 0.61%. Distance from 52-week low is 23.72% and -5.82% from its 52-week high. The company has generated returns on investments over the last 12 months (0.51%).
Merck & Co Inc quarterly earnings per share for the current quarter are estimated at $2.06 with sales reaching $15.12B over the same period.The EPS is expected to grow by 468.98% this year, but quarterly earnings will post 6.10% year-over-year. Quarterly sales are estimated to grow 9.70% in year-over-year returns.
Merck & Co Inc (MRK) Top Institutional Holders
4,271 institutions hold shares in Merck & Co Inc (MRK), with institutional investors hold 78.64% of the company’s shares. The shares outstanding are 2.53B, and float is at 2.53B with Short Float at 0.66%. Institutions hold 78.59% of the Float.
The top institutional shareholder in the company is Vanguard Group Inc with over 243.64 million shares valued at $28.11 billion. The investor’s holdings represent 9.60% of the MRK Shares outstanding. As of Jun 29, 2023, the second largest holder is Blackrock Inc. with 205.65 million shares valued at $23.73 billion to account for 8.10% of the shares outstanding. The other top investors are State Street Corporation which holds 118.56 million shares representing 4.67% and valued at over $13.68 billion, while Wellington Management Group, LLP holds 3.04% of the shares totaling 77.25 million with a market value of $8.91 billion.
Merck & Co Inc (MRK) Insider Activity
The most recent transaction is an insider purchase by Merck & Co., Inc.,the company’s10% Owner. SEC filings show that Merck & Co., Inc. bought 21,397,205 shares of the company’s common stock on Mar 11 ’24 at a price of $23.00 per share for a total of $492.14 million. Following the purchase, the insider now owns 1000.0 shares.
Merck & Co Inc disclosed in a document filed with the SEC on Feb 14 ’24 that Davis Robert M (Chairman, CEO & President) sold a total of 85,021 shares of the company’s common stock. The trade occurred on Feb 14 ’24 and was made at $125.40 per share for $10.66 million. Following the transaction, the insider now directly holds 0.35 million shares of the MRK stock.
Still, SEC filings show that on Feb 14 ’24, Litchfield Caroline (EVP & CFO) disposed off 38,291 shares at an average price of $125.50 for $4.81 million. The insider now directly holds 50,908 shares of Merck & Co Inc (MRK).
